I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 4 studies | 26% ± 7% | |
| glutamatergic neuron | 4 studies | 32% ± 5% | |
| astrocyte | 3 studies | 24% ± 4% | |
| oligodendrocyte | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 4 studies | 26% ± 7% | |
| glutamatergic neuron | 4 studies | 32% ± 5% | |
| astrocyte | 3 studies | 24% ± 4% | |
| oligodendrocyte | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 232.22 | 245 / 245 | 100% | 2.80 | 500 / 502 |
| thymus | 100% | 298.69 | 653 / 653 | 99% | 3.18 | 600 / 605 |
| breast | 100% | 230.52 | 457 / 459 | 100% | 3.79 | 1113 / 1118 |
| brain | 99% | 204.29 | 2619 / 2642 | 100% | 3.54 | 704 / 705 |
| skin | 100% | 260.39 | 1809 / 1809 | 97% | 2.72 | 458 / 472 |
| kidney | 100% | 179.71 | 89 / 89 | 95% | 2.28 | 860 / 901 |
| esophagus | 100% | 203.66 | 1442 / 1445 | 95% | 2.03 | 174 / 183 |
| bladder | 100% | 257.67 | 21 / 21 | 94% | 2.21 | 476 / 504 |
| pancreas | 99% | 150.42 | 325 / 328 | 95% | 2.01 | 169 / 178 |
| ovary | 99% | 217.19 | 179 / 180 | 94% | 2.64 | 406 / 430 |
| uterus | 100% | 201.81 | 170 / 170 | 90% | 2.03 | 412 / 459 |
| lung | 99% | 220.09 | 573 / 578 | 90% | 1.86 | 1045 / 1155 |
| stomach | 100% | 168.41 | 358 / 359 | 88% | 1.83 | 253 / 286 |
| intestine | 100% | 229.42 | 966 / 966 | 88% | 1.65 | 462 / 527 |
| adrenal gland | 98% | 238.24 | 254 / 258 | 89% | 2.37 | 205 / 230 |
| liver | 100% | 184.28 | 225 / 226 | 51% | 0.90 | 206 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 2.63 | 29 / 29 |
| spleen | 100% | 369.17 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.03 | 1 / 1 |
| adipose | 100% | 218.17 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 153.52 | 1317 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 2.14 | 44 / 45 |
| eye | 0% | 0 | 0 / 0 | 98% | 2.40 | 78 / 80 |
| peripheral blood | 95% | 269.85 | 886 / 929 | 0% | 0 | 0 / 0 |
| heart | 94% | 121.19 | 809 / 861 | 0% | 0 | 0 / 0 |
| muscle | 93% | 84.27 | 745 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF490 |
| Protein name | Zinc finger protein 490 |
| Synonyms | KIAA1198 |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | F8WDW6 ENST00000440366.1 ENST00000414906.5 C9JID3 ENST00000311437.11 Q9ULM2 |
